RBM17 and neoplasm: To validate the role of MSI2 and RBM17 in radioresistance, we constructed stable transgenic cell lines with knockdown of MSI2 and RBM17 and overexpressed another molecule in the knockdown cell line, and nude mice were tumor‐loaded subcutaneously.